We’re excited to announce that the programme for the 8th International TREAT-NMD® Conference is now available! Taking place from 10–12 February 2026 at the Altis Grand Hotel in Lisbon, Portugal, this global event will bring together clinicians, researchers, patient advocates, and industry leaders under the theme: Addressing Challenges in a Changing World
This year’s programme tackles some of the most pressing issues in neuromuscular healthcare, including:
- Patient involvement in clinical trials
- Global standards of care
- The future of gene therapy
- Regulatory complexity and uncertainty
- Access to new therapies worldwide
- Market access, pricing, and reimbursement
With keynote speakers, expert-led sessions, panel discussions, and networking opportunities, the conference promises to be a dynamic platform for collaboration and innovation. View the programme here:
Registration Details
Standard registration opens on 1 August 2025. Fees include access to all official conference sessions, the exhibition, the opening reception, the evening networking dinner, as well as coffee breaks and lunches.
Tickets can be purchased via the official registration page. For corporate, group, or bulk registrations, please contact: education@treat-nmd.com.
Call for Abstracts
Delegates are invited to submit abstracts for poster presentations. This is an opportunity to showcase achievements, share practical ideas, and foster international collaboration in the field of neuromuscular healthcare.
Submissions are welcome on the following topics:
– Collaborative projects that improve healthcare in rare neuromuscular conditions
– Partnerships with TREAT-NMD® that benefit the global community
– Use of TREAT-NMD® resources in practice
Key Dates:
Abstract submissions open: 20 May 2025
Abstract submission deadline: 18 November 2025
Notification of acceptance: 8 December 2025
Further details and submission guidelines are available here
The TREAT-NMD® Conference 2026 promises to be a valuable opportunity for learning, networking, and advancing global efforts in neuromuscular care.
